株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ラットモデルの世界市場 - 2021年までの予測:非近交系ラット、近交系ラット、ノックアウトラット

Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021

発行 MarketsandMarkets 商品コード 338487
出版日 ページ情報 英文 256 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.82円で換算しております。
Back to Top
ラットモデルの世界市場 - 2021年までの予測:非近交系ラット、近交系ラット、ノックアウトラット Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021
出版日: 2017年01月12日 ページ情報: 英文 256 Pages
概要

ラットモデル市場は、2016年の3億8770万米ドルから、2021年までに5億8890万米ドルまで拡大すると見られています。市場は、2016年〜2021年のCAGR (複合年間成長率) で、8.7%の成長が予測されています。

当レポートでは、世界のラットモデル市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • ラットモデル市場の概要
  • 地域別分析:世界のラットケア用品市場 (種類別)
  • 世界のラットモデル市場:治療領域別
  • 世界のラットモデル市場の地域別スナップショット

第5章 ラットモデルの世界市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 ラットモデルの世界市場:治験・調査研究の評価

  • イントロダクション
  • 治験
  • 調査研究

第7章 ラットモデルの世界市場:モデルの種類別

  • イントロダクション
  • 非近交系ラット
  • 近交系ラット
  • ノックアウト/遺伝子改変ラット
  • ハイブリッド/コンジェニックラット
  • 条件付け/外科的改変ラット
  • 免疫不全ラット

第8章 ラットモデルの世界市場:サービス別

  • イントロダクション
  • 繁殖
  • 細胞凍結
  • 検疫
  • 再導出
  • モデルのインライセンス (導入)
  • 遺伝子検査
  • その他

第9章 ラットモデルの世界市場:技術別

  • イントロダクション
  • CRISPR
  • 微量注入
  • ES細胞注入
  • 核移植
  • その他

第10章 ラットモデルの世界市場:治療領域別

  • イントロダクション
  • 毒物学
  • 腫瘍学
  • 免疫・炎症
  • 神経学
  • 糖尿病
  • その他

第11章 ラットモデルの世界市場:エンドユーザー別

  • イントロダクション
  • 製薬・バイオ企業
  • 学術・研究機関
  • 開発業務受託機関 (CRO)

第12章 ラットモデルの世界市場:ケア用品別

  • イントロダクション
  • ケージ
  • 寝わら
  • その他

第13章 ラットモデルの世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第14章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況と動向
  • 契約、提携、パートナーシップ
  • 買収
  • 事業拡大
  • 新製品発売
  • その他の戦略

第15章 企業プロファイル

  • イントロダクション
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • TACONIC BIOSCIENCES, INC.
  • ENVIGO
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • JANVIER LABS
  • GENOWAY S.A.
  • BIOMERE
  • TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
  • HORIZON DISCOVERY GROUP PLC
  • TRANSVIRAGEN, INC.

第16章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 3682

"The rat model market is projected to reach USD 588.9 million by 2021 from USD 387.7 million in 2016, growing at a CAGR of 8.7% during the forecast period."

Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the rat model market. In addition to this, increase in R&D activities in pharmaceutical industries is further stimulating the market growth. However, increased benefits of cryopreservation and regulations & laws formulated for ethical use of animals in research are restraining the growth of the market to a certain extent.

The global rat model market is segmented on the basis of model type, service, technology, therapeutic area, end user, care product, and region. In 2016, North America is expected to account for the largest share of the global rat model market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate during the forecast period. Factors such as less stringent regulations on the use of animal models for research in the region, international alliances for R&D activities in China, growth in regenerative medicine, biomedical, and medical research in Japan, growing presence of global players, development of bioclusters to boost biotechnology industry in India, ongoing biomedical research activities in Australia, and rising pharmaceutical and biotechnology R&D activities are likely to propel the market in the Asia-Pacific region.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (expansions; new product launches; collaborations/agreement/partnerships/alliance, funding; licensing, contract, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the rat model market place.

  • By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
  • By Designation: Director Level: 58%, C-level: 25%, Others: 17%
  • By Region: North America: 46%, Europe: 31%, APAC: 15%, RoW: 8%

The prominent players in the global rat model market include Charles River Laboratories International, Inc. (U.S.), Envigo (U.K.), and Taconic Biosciences, Inc. (U.S.). Other players include Laboratory Corporation of America Holdings (U.S.), Janvier Labs (France), Transviragen, Inc. (U.S.), genOway SA (France), Biomere (U.S.), Transposagen Biopharmaceuticals, Inc. (U.S.), and Horizon Discovery Group plc (U.K.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the products and services offered by top players in the rat model market. The report analyzes the rat model market by model type, service, technology, therapeutic area, end user, care product, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the rat model market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for rat model across various regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the rat model market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the rat model market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key Insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET FORECAST METHODOLOGY
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. RAT MODEL MARKET OVERVIEW
  • 4.2. REGIONAL ANALYSIS: GLOBAL RAT CARE PRODUCT MARKET, BY TYPE
  • 4.3. GLOBAL RAT MODEL MARKET, BY THERAPEUTIC AREA, 2016 & 2021
  • 4.4. REGIONAL SNAPSHOT OF THE GLOBAL RAT MODEL MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Advancements in gene editing tools set to augment the demand for rat models
      • 5.2.1.2. Advantages offered by rats over mice
      • 5.2.1.3. Continuous support in the form of investments and grants
      • 5.2.1.4. Increased demand for personalized humanized rat models due to growing consumption of personalized medicines
      • 5.2.1.5. Increase in R&D activities carried out by pharmaceutical and biotechnology companies
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Regulations & laws formulated for ethical use of animals
        • 5.2.2.1.1. The Animal Welfare Act (AWA)
        • 5.2.2.1.2. Public health service policy (PHS) on humane care and use of laboratory animals
      • 5.2.2.2. Increased benefits offered by cryopreservation
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increased production of monoclonal antibodies
      • 5.2.3.2. Rising demand of humanized rat models
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Advancements in zebrafish model development
      • 5.2.4.2. Development of methods alternative to animal testing

6. CLINICAL TRIALS & RESEARCH STUDIES ASSESSMENT

  • 6.1. INTRODUCTION
  • 6.2. CLINICAL TRIALS
  • 6.3. RESEARCH STUDIES

7. GLOBAL RAT MODEL MARKET, BY MODEL TYPE

  • 7.1. INTRODUCTION
  • 7.2. OUTBRED RATS
  • 7.3. INBRED RATS
  • 7.4. KNOCKOUT/GENETICALLY ENGINEERED RATS
  • 7.5. HYBRID/CONGENIC RATS
  • 7.6. CONDITIONED/SURGICALLY MODIFIED RATS
  • 7.7. IMMUNODEFICIENT RATS

8. GLOBAL RAT MODEL MARKET, BY SERVICE

  • 8.1. INTRODUCTION
  • 8.2. BREEDING
  • 8.3. CRYOPRESERVATION
  • 8.4. QUARANTINE
  • 8.5. REDERIVATION
  • 8.6. MODEL IN-LICENSING
  • 8.7. GENETIC TESTING
  • 8.8. OTHERS
    • 8.8.1. SURGICAL SERVICES
    • 8.8.2. LINE RESCUE SERVICES
    • 8.8.3. IN VIVO PHARMACOLOGY SERVICES

9. GLOBAL RAT MODEL MARKET, BY TECHNOLOGY

  • 9.1. INTRODUCTION
  • 9.2. CRISPR
  • 9.3. MICROINJECTION
  • 9.4. EMBRYONIC STEM CELL INJECTION
  • 9.5. NUCLEAR TRANSFER
  • 9.6. OTHER TECHNOLOGIES

10. GLOBAL RAT MODEL MARKET, BY THERAPEUTIC AREA

  • 10.1. INTRODUCTION
  • 10.2. TOXICOLOGY
  • 10.3. ONCOLOGY
    • 10.3.1. NEW PRODUCT LAUNCHES FOR ONCOLOGY RESEARCH
    • 10.3.2. CONTINUOUS GRANTS/FUNDS TO SUPPORT CANCER RESEARCH STUDIES
  • 10.4. IMMUNOLOGY AND INFLAMMATION
  • 10.5. NEUROLOGY
  • 10.6. DIABETES
  • 10.7. OTHERS

11. GLOBAL RAT MODEL MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 11.3. ACADEMIC & RESEARCH INSTITUTIONS
  • 11.4. CONTRACT RESEARCH ORGANIZATIONS (CRO)

12. GLOBAL RAT MODEL MARKET, BY CARE PRODUCT

  • 12.1. INTRODUCTION
  • 12.2. CAGES
  • 12.3. FEED
  • 12.4. BEDDING
  • 12.5. OTHER CARE PRODUCTS

13. GLOBAL RAT MODEL MARKET, BY REGION

  • 13.1. INTRODUCTION
  • 13.2. NORTH AMERICA
    • 13.2.1. U.S.
      • 13.2.1.1. Growing biomedical research in the U.S.
      • 13.2.1.2. Preclinical activities by CROs and pharmaceutical R&D
      • 13.2.1.3. Continued and responsible use of animals ensured by animal care organizations
      • 13.2.1.4. Development of biosimilars product boosting the demand for preclinical services
      • 13.2.1.5. Monoclonal antibody production to augment the use of rat models
      • 13.2.1.6. Partnership between CROs and pharmaceutical companies
    • 13.2.2. CANADA
      • 13.2.2.1. Growing stem cell research activities in Canada
      • 13.2.2.2. Government support for development of protein drugs is expected to drive the rat model market
  • 13.3. EUROPE
    • 13.3.1. GERMANY
      • 13.3.1.1. Launch of Pro-Test Deutschland
      • 13.3.1.2. Flourishing biotechnology industry
    • 13.3.2. U.K.
      • 13.3.2.1. Investors demand strong statistics for animal studies in the U.K.
      • 13.3.2.2. Increase in cell therapy preclinical research
    • 13.3.3. FRANCE
      • 13.3.3.1. Funding for Rare Disease Projects in France
    • 13.3.4. RUSSIA
      • 13.3.4.1. Growing biomedical industry in Russia
    • 13.3.5. REST OF EUROPE
      • 13.3.5.1. Growth in biotech and pharma sector of Italy
      • 13.3.5.2. Growing investments in research by Sweden & Denmark
      • 13.3.5.3. Focus on rare disease research projects
      • 13.3.5.4. Growth in Biosimilars market to lead to increased preclinical activities
  • 13.4. ASIA-PACIFIC
    • 13.4.1. CHINA
      • 13.4.1.1. International alliances for R&D activities in China
      • 13.4.1.2. Initiatives to reduce longer approval times
      • 13.4.1.3. Intellectual property (IP) breaches, a challenge for the China market
      • 13.4.1.4. Mandatory animal testing for all pharmaceutical drugs and cosmetics in China
      • 13.4.1.5. Increasing investments from government and private sectors in China's life sciences sector
    • 13.4.2. JAPAN
      • 13.4.2.1. Growth in biomedical and medical research in Japan
      • 13.4.2.2. Research in regenerative medicine
      • 13.4.2.3. Focus on cancer research and treatment
    • 13.4.3. INDIA
      • 13.4.3.1. Growth of the pharmaceutical industry in India
      • 13.4.3.2. Development of bio-clusters to boost India's biotechnology
      • 13.4.3.3. Growing presence of global players
      • 13.4.3.4. Shift of outsourcing preclinical activities from India to European nations
      • 13.4.3.5. Weak intellectual property environment in India
      • 13.4.3.6. Limited infrastructural facilities in India, a major hindrance for growth of the rat model market
    • 13.4.4. REST OF ASIA-PACIFIC
      • 13.4.4.1. Ongoing Biomedical research activities in Australia to strengthen the market
      • 13.4.4.2. Growth in translational and biomedical research in Singapore
      • 13.4.4.3. Increase in animal research in Malaysia
      • 13.4.4.4. Government support for strong academic and commercial R&D activities in Taiwan
      • 13.4.4.5. Rising pharmaceutical and biotechnology R&D activities in Korea
  • 13.5. REST OF THE WORLD
      • 13.5.1.1. Pharmaceutical, biotechnology, and research industries in Brazil to drive market growth
      • 13.5.1.2. Favorable business environment for pharmaceutical and biotechnology industries in Saudi Arabia and the UAE
      • 13.5.1.3. Increasing investments in Mexico

14. COMPETITIVE LANDSCAPE

  • 14.1. OVERVIEW
  • 14.2. MARKET SHARE ANALYSIS
    • 14.2.1. INTRODUCTION
    • 14.2.2. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (U.S.)
    • 14.2.3. ENVIGO (U.K.)
    • 14.2.4. TACONIC BIOSCIENCES, INC. (U.S.)
  • 14.3. COMPETITIVE SITUATION AND TRENDS
  • 14.4. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
  • 14.5. ACQUISITIONS
  • 14.6. EXPANSIONS
  • 14.7. NEW PRODUCT LAUNCHES
  • 14.8. OTHER STRATEGIES

15. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 15.1. INTRODUCTION
  • 15.2. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 15.3. TACONIC BIOSCIENCES, INC.
  • 15.4. ENVIGO
  • 15.5. LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 15.6. JANVIER LABS
  • 15.7. GENOWAY S.A.
  • 15.8. BIOMERE
  • 15.9. TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
  • 15.10. HORIZON DISCOVERY GROUP PLC
  • 15.11. TRANSVIRAGEN, INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

16. APPENDIX

  • 16.1. DISCUSSION GUIDE
  • 16.2. OTHER DEVELOPMENTS
    • 16.2.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • 16.2.2. TACONIC BIOSCIENCES, INC.
    • 16.2.3. ENVIGO
    • 16.2.4. LABORATORY CORPORATION OF AMERICA HOLDINGS
    • 16.2.5. GENOWAY S.A.
    • 16.2.6. HORIZON DISCOVERY GROUP PLC
  • 16.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 16.5. AVAILABLE CUSTOMIZATIONS
  • 16.6. RELATED REPORTS
  • 16.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED ON RAT MODELS
  • TABLE 2: INDICATIVE LIST OF RESEARCH STUDIES CONDUCTED ON RAT MODELS
  • TABLE 3: GLOBAL RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD MILLION)
  • TABLE 4: RAT MODEL MARKET FOR OUTBRED RATS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 5: RAT MODEL MARKET FOR INBRED RATS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 6: RAT MODEL MARKET FOR KNOCKOUT/GENETICALLY ENGINEERED RATS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 7: RAT MODEL MARKET FOR HYBRID/CONGENIC RATS, BY REGION, 2013-2021 (USD THOUSAND)
  • TABLE 8: RAT MODEL MARKET FOR CONDITIONED/SURGICALLY MODIFIED RATS, BY REGION, 2013-2021 (USD THOUSAND)
  • TABLE 9: RAT MODEL MARKET FOR IMMUNODEFICIENT RATS, BY REGION, 2013-2021 (USD THOUSAND)
  • TABLE 10: GLOBAL RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 11: RAT MODEL MARKET FOR BREEDING, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 12: RAT MODEL MARKET FOR CRYOPRESERVATION, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 13: RAT MODEL MARKET FOR QUARANTINE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 14: RAT MODEL MARKET FOR REDERIVATION, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 15: RAT MODEL MARKET FOR MODEL IN-LICENSING, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 16: RAT MODEL MARKET FOR GENETIC TESTING, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 17: RAT MODEL MARKET FOR OTHERS , BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 18: GLOBAL RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 19: RAT MODEL MARKET FOR CRISPR, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 20: RAT MODEL MARKET FOR MICROINJECTION, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 21: RAT MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 22: RAT MODEL MARKET FOR NUCLEAR TRANSFER, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 23: RAT MODEL MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 24: GLOBAL RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 25: RAT MODEL MARKET IN TOXICOLOGY, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 26: LIST OF CANCER RESEARCH STUDIES USING RAT MODELS
  • TABLE 27: RAT MODEL MARKET IN ONCOLOGY, BY REGION, 2013-2021 (USD THOUSAND)
  • TABLE 28: RAT MODEL MARKET IN IMMUNOLOGY AND INFLAMMATION, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 29: INDICATIVE LIST OF NEUROLOGICAL RESEARCH STUDIES USING RAT MODEL
  • TABLE 30: RAT MODEL MARKET IN NEUROLOGY, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 31: RAT MODEL MARKET IN DIABETES, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 32: RAT MODEL MARKET IN OTHERS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 33: GLOBAL RAT MODEL MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 34: RAT MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 35: RAT MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 36: RAT MODEL MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 37: GLOBAL RAT CARE PRODUCT MARKET, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 38: RAT CARE PRODUCT MARKET FOR CAGES, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 39: RAT CARE PRODUCT MARKET FOR FEED, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 40: RAT CARE PRODUCT MARKET FOR BEDDING, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 41: RAT CARE PRODUCT MARKET FOR OTHER CARE PRODUCTS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 42: RAT MODEL MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: RAT MODEL MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 46: NORTH AMERICA: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 47: NORTH AMERICA: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 48: NORTH AMERICA: RAT MODEL MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: RAT CARE PRODUCT MARKET, BY CARE PRODUCT, 2014-2021 (USD THOUSAND)
  • TABLE 50: NIH FUNDING FOR PROJECTS RELATED TO ANIMAL MODELS
  • TABLE 51: ASSOCIATIONS DIRECTLY RELATED TO THE ANIMAL MODEL MARKET
  • TABLE 52: ASSOCIATIONS INDIRECTLY RELATED TO THE ANIMAL MODEL MARKET
  • TABLE 53: U.S.: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD MILLION)
  • TABLE 54: U.S.: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 55: U.S.: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD MILLION)
  • TABLE 56: U.S.: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 57: U.S.: RAT MODEL MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 58: CANADA: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 59: CANADA: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 60: CANADA: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 61: CANADA: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 62: CANADA: RAT MODEL MARKET, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 63: EUROPE: RAT MODEL MARKET, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 64: EUROPE: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: EUROPE: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 66: EUROPE: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 67: EUROPE: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 68: EUROPE: RAT MODEL MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 69: EUROPE: RAT CARE PRODUCT MARKET, BY CARE PRODUCT, 2014-2021 (USD THOUSAND)
  • TABLE 70: GERMANY: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 71: GERMANY: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 72: GERMANY: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 73: GERMANY: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 74: GERMANY: RAT MODEL MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: U.K.: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 76: U.K.: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 77: U.K.: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 78: U.K.: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 79: U.K.: RAT MODEL MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 80: FRANCE: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 81: FRANCE: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 82: FRANCE: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 83: FRANCE: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 84: FRANCE: RAT MODEL MARKET, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 85: RUSSIA: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 86: RUSSIA: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 87: RUSSIA: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 88: RUSSIA: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 89: RUSSIA: RAT MODEL MARKET, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 90: ROE: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 91: ROE: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 92: ROE: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 93: ROE: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 94: ROE: RAT MODEL MARKET, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 95: ASIA-PACIFIC: RAT MODEL MARKET, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 96: ASIA-PACIFIC: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 97: ASIA-PACIFIC: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 98: ASIA-PACIFIC: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 99: ASIA-PACIFIC: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 100: ASIA-PACIFIC: RAT MODEL MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 101: ASIA-PACIFIC: RAT CARE PRODUCTS MARKET, BY CARE PRODUCT, 2014-2021 (USD THOUSAND)
  • TABLE 102: CHINA: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 103: CHINA: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 104: CHINA: RAT MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 105: CHINA: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 106: CHINA: RAT MODEL MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 107: JAPAN: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 108: JAPAN: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 109: JAPAN.: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 110: JAPAN: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 111: JAPAN: RAT MODEL MARKET, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 112: INDIA: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 113: INDIA: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 114: INDIA: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 115: INDIA: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 116: INDIA: RAT MODEL MARKET, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 117: REST OF APAC: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 118: REST OF APAC: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 119: REST OF APAC: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 120: REST OF APAC: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 121: REST OF APAC: RAT MODEL MARKET, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 122: ROW: RAT MODEL MARKET, BY MODEL TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 123: ROW: RAT MODEL MARKET, BY SERVICE, 2014-2021 (USD THOUSAND)
  • TABLE 124: ROW: RAT MODEL MARKET, BY THERAPEUTIC AREA, 2014-2021 (USD THOUSAND)
  • TABLE 125: ROW: RAT MODEL MARKET, BY TECHNOLOGY, 2014-2021 (USD THOUSAND)
  • TABLE 126: ROW: RAT MODEL MARKET, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 127: ROW: RAT CARE PRODUCT MARKET, BY CARE PRODUCT, 2014-2021 (USD THOUSAND)
  • TABLE 128: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013-2016
  • TABLE 129: ACQUISITIONS, 2013-2016
  • TABLE 130: EXPANSIONS, 2013-2016
  • TABLE 131: NEW PRODUCT LAUNCHES, 2013-2016
  • TABLE 132: OTHER STRATEGIES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL RAT MODEL MARKET: RESEARCH METHODOLOGY
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: GLOBAL RAT MODEL MARKET, BY THERAPEUTIC AREA (2016)
  • FIGURE 9: GLOBAL RAT MODEL MARKET, BY MODEL TYPE
  • FIGURE 10: GLOBAL RAT MODEL MARKET, BY SERVICE
  • FIGURE 11: GLOBAL RAT MODEL MARKET, BY END USER
  • FIGURE 12: GLOBAL RAT MODEL MARKET, BY TECHNOLOGY
  • FIGURE 13: GLOBAL RAT MODEL MARKET, BY CARE PRODUCT
  • FIGURE 14: THE ASIA-PACIFIC RAT MODEL MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: ATTRACTIVE OPPORTUNITIES IN THE GLOBAL RAT MODEL MARKET
  • FIGURE 16: NORTH AMERICA DOMINATED THE GLOBAL RAT CARE PRODUCT MARKET IN 2016
  • FIGURE 17: THE TOXICOLOGY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL RAT MODEL MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: THE ASIA-PACIFIC REGION TO WITNESS THE HIGHEST GROWTH IN THE GLOBAL RAT MODEL MARKET FROM 2016 TO 2021
  • FIGURE 19: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: CLINICAL TRIALS USING RAT MODELS, BY INDICATION
  • FIGURE 21: CLINICAL TRIALS USING RAT MODELS, BY PHASE
  • FIGURE 22: RESEARCH STUDIES USING RAT MODELS, BY INDICATION
  • FIGURE 23: BASED ON MODEL TYPE, THE OUTBRED RATS SEGMENT IS ESTIMATED TO DOMINATE THE RAT MODEL MARKET IN 2016
  • FIGURE 24: BASED ON SERVICE, THE BREEDING SEGMENT IS ESTIMATED TO DOMINATE THE RAT MODEL MARKET IN 2016
  • FIGURE 25: RAT MODEL MARKET, BY TECHNOLOGY, 2016-2021
  • FIGURE 26: BASED ON THERAPEUTIC AREA, THE TOXICOLOGY SEGMENT IS ESTIMATED TO DOMINATE THE RAT MODEL MARKET IN 2016
  • FIGURE 27: BASED ON END USER, THE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT IS ESTIMATED TO DOMINATE THE RAT MODEL MARKET IN 2016
  • FIGURE 28: BASED ON CARE PRODUCT, THE CAGES SEGMENT IS ESTIMATED TO DOMINATE THE RAT CARE PRODUCTS MARKET IN 2016
  • FIGURE 29: NORTH AMERICA DOMINATES THE MARKET FOR RAT MODEL PRODUCTS
  • FIGURE 30: NORTH AMERICA: RAT MODEL MARKET SNAPSHOT
  • FIGURE 31: EUROPE: RAT MODEL MARKET SNAPSHOT
  • FIGURE 32: NUMBER OF CELL THERAPY PRECLINICAL STUDIES LISTED IN THE U.K. PRECLINICAL RESEARCH DATABASE , 2013-2016
  • FIGURE 33: ASIA-PACIFIC: RAT MODEL MARKET SNAPSHOT
  • FIGURE 34: REST OF THE WORLD: RAT MODEL MARKET SNAPSHOT
  • FIGURE 35: MAJOR PLAYERS FOCUSING ON INORGANIC GROWTH STRATEGIES
  • FIGURE 36: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 37: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 38: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, BY COMPANY (2013-2016)
  • FIGURE 39: ACQUISITIONS, BY COMPANY (2013-2016)
  • FIGURE 40: EXPANSIONS, BY COMPANY (2013-2016)
  • FIGURE 41: NEW PRODUCT LAUNCHES, BY COMPANY (2013-2016)
  • FIGURE 42: OTHER STRATEGIES, BY COMPANY (2013-2016)
  • FIGURE 43: GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
  • FIGURE 44: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • FIGURE 45: LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
  • FIGURE 46: GENOWAY S.A.: COMPANY SNAPSHOT
  • FIGURE 47: HORIZON DISCOVERY GROUP PLC: COMPANY SNAPSHOT
Back to Top